Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Price:
18.7
CNY
-0.27%
Market Closed
Market Cap:
¥4.3B
Income Statement
Earnings Waterfall
Wuhan Easy Diagnosis Biomedicine Co Ltd
Wuhan Easy Diagnosis Biomedicine Co Ltd
Income Statement
Wuhan Easy Diagnosis Biomedicine Co Ltd
Wuhan Easy Diagnosis Biomedicine Co Ltd
Currency: CNY
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
0
|
5
|
0
|
10
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Revenue |
179
N/A
|
180
+1%
|
176
-2%
|
186
+5%
|
180
-3%
|
184
+2%
|
181
-1%
|
163
-10%
|
440
+170%
|
682
+55%
|
959
+41%
|
1 608
+68%
|
1 740
+8%
|
2 257
+30%
|
2 830
+25%
|
4 640
+64%
|
6 942
+50%
|
8 361
+20%
|
10 530
+26%
|
8 415
-20%
|
5 815
-31%
|
3 686
-37%
|
750
-80%
|
438
-42%
|
366
-16%
|
349
-5%
|
350
+0%
|
359
+3%
|
335
-7%
|
351
+5%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||
| Cost of Revenue |
(38)
|
(39)
|
(40)
|
(43)
|
(42)
|
(45)
|
(47)
|
(46)
|
(86)
|
(136)
|
(209)
|
(367)
|
(430)
|
(566)
|
(707)
|
(1 220)
|
(2 093)
|
(2 587)
|
(3 991)
|
(3 600)
|
(2 684)
|
(2 037)
|
(300)
|
(172)
|
(132)
|
(128)
|
(214)
|
(186)
|
(178)
|
(210)
|
|
| Gross Profit |
141
N/A
|
141
0%
|
136
-4%
|
143
+5%
|
138
-3%
|
139
+0%
|
135
-3%
|
117
-13%
|
354
+204%
|
545
+54%
|
750
+38%
|
1 240
+65%
|
1 310
+6%
|
1 692
+29%
|
2 123
+25%
|
3 421
+61%
|
4 849
+42%
|
5 775
+19%
|
6 540
+13%
|
4 816
-26%
|
3 130
-35%
|
1 649
-47%
|
449
-73%
|
266
-41%
|
234
-12%
|
221
-6%
|
137
-38%
|
173
+27%
|
157
-9%
|
142
-10%
|
|
| Operating Income | |||||||||||||||||||||||||||||||
| Operating Expenses |
(61)
|
(63)
|
(72)
|
(78)
|
(81)
|
(88)
|
(101)
|
(97)
|
(116)
|
(126)
|
(192)
|
(247)
|
(295)
|
(347)
|
(432)
|
(455)
|
(527)
|
(636)
|
(1 393)
|
(1 436)
|
(1 207)
|
(1 036)
|
(387)
|
(300)
|
(306)
|
(324)
|
(208)
|
(313)
|
(313)
|
(337)
|
|
| Selling, General & Administrative |
(44)
|
(48)
|
(52)
|
(56)
|
(57)
|
(59)
|
(65)
|
(65)
|
(79)
|
(94)
|
(134)
|
(175)
|
(208)
|
(234)
|
(303)
|
(346)
|
(401)
|
(442)
|
(1 012)
|
(927)
|
(830)
|
(762)
|
(280)
|
(287)
|
(309)
|
(290)
|
(152)
|
(141)
|
(157)
|
(192)
|
|
| Research & Development |
(23)
|
(24)
|
(27)
|
(30)
|
(34)
|
(36)
|
(37)
|
(36)
|
(40)
|
(47)
|
(70)
|
(86)
|
(100)
|
(114)
|
(133)
|
(139)
|
(140)
|
(209)
|
(388)
|
(393)
|
(403)
|
(340)
|
(141)
|
(135)
|
(125)
|
(121)
|
(110)
|
(107)
|
(101)
|
(92)
|
|
| Depreciation & Amortization |
(1)
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
7
|
10
|
8
|
8
|
9
|
6
|
3
|
3
|
3
|
15
|
14
|
14
|
13
|
1
|
8
|
30
|
15
|
15
|
18
|
(116)
|
26
|
66
|
65
|
122
|
127
|
87
|
77
|
(67)
|
(55)
|
(52)
|
|
| Operating Income |
80
N/A
|
78
-3%
|
64
-18%
|
65
+2%
|
57
-13%
|
50
-11%
|
34
-33%
|
20
-42%
|
238
+1 115%
|
419
+76%
|
558
+33%
|
993
+78%
|
1 016
+2%
|
1 344
+32%
|
1 691
+26%
|
2 966
+75%
|
4 322
+46%
|
5 139
+19%
|
5 147
+0%
|
3 380
-34%
|
1 924
-43%
|
614
-68%
|
62
-90%
|
(34)
N/A
|
(72)
-113%
|
(103)
-43%
|
(71)
+31%
|
(140)
-97%
|
(156)
-11%
|
(195)
-25%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||
| Interest Income Expense |
2
|
2
|
4
|
6
|
8
|
10
|
8
|
8
|
4
|
4
|
4
|
2
|
5
|
7
|
7
|
12
|
34
|
46
|
74
|
100
|
108
|
122
|
120
|
115
|
116
|
110
|
127
|
144
|
135
|
134
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
1
|
1
|
0
|
(21)
|
0
|
0
|
0
|
0
|
0
|
0
|
(141)
|
0
|
(141)
|
(141)
|
(38)
|
0
|
1
|
1
|
(15)
|
0
|
2
|
2
|
|
| Total Other Income |
(1)
|
(4)
|
3
|
3
|
8
|
8
|
5
|
2
|
(6)
|
(6)
|
(6)
|
(2)
|
(0)
|
(3)
|
(3)
|
(3)
|
(5)
|
(2)
|
(4)
|
(5)
|
(6)
|
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
(9)
|
(10)
|
(9)
|
7
|
|
| Pre-Tax Income |
81
N/A
|
76
-7%
|
71
-7%
|
73
+4%
|
72
-2%
|
67
-6%
|
47
-31%
|
30
-36%
|
238
+695%
|
419
+76%
|
557
+33%
|
972
+75%
|
1 020
+5%
|
1 349
+32%
|
1 695
+26%
|
2 974
+76%
|
4 351
+46%
|
5 182
+19%
|
5 076
-2%
|
3 476
-32%
|
1 885
-46%
|
588
-69%
|
140
-76%
|
78
-44%
|
41
-48%
|
4
-91%
|
32
+759%
|
(6)
N/A
|
(28)
-402%
|
(51)
-79%
|
|
| Net Income | |||||||||||||||||||||||||||||||
| Tax Provision |
(11)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(4)
|
(2)
|
(35)
|
(61)
|
(81)
|
(148)
|
(152)
|
(199)
|
(248)
|
(448)
|
(664)
|
(784)
|
(696)
|
(443)
|
(198)
|
(11)
|
(71)
|
(62)
|
(59)
|
(55)
|
(6)
|
1
|
7
|
3
|
|
| Income from Continuing Operations |
71
|
68
|
63
|
65
|
64
|
60
|
43
|
28
|
203
|
357
|
476
|
823
|
869
|
1 150
|
1 447
|
2 526
|
3 687
|
4 398
|
4 380
|
3 032
|
1 687
|
577
|
69
|
16
|
(18)
|
(51)
|
27
|
(5)
|
(22)
|
(48)
|
|
| Income to Minority Interest |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(7)
|
(15)
|
(21)
|
(32)
|
(33)
|
(65)
|
(93)
|
(152)
|
(172)
|
(138)
|
(127)
|
(61)
|
6
|
16
|
46
|
62
|
48
|
44
|
43
|
55
|
|
| Net Income (Common) |
70
N/A
|
67
-5%
|
61
-8%
|
64
+4%
|
63
-1%
|
58
-8%
|
42
-29%
|
27
-34%
|
201
+637%
|
353
+75%
|
469
+33%
|
808
+72%
|
848
+5%
|
1 118
+32%
|
1 413
+26%
|
2 461
+74%
|
3 594
+46%
|
4 246
+18%
|
4 208
-1%
|
2 895
-31%
|
1 561
-46%
|
515
-67%
|
75
-85%
|
32
-58%
|
28
-13%
|
11
-62%
|
75
+605%
|
39
-48%
|
22
-44%
|
7
-68%
|
|
| EPS (Diluted) |
1.4
N/A
|
1.08
-23%
|
1.08
N/A
|
0.95
-12%
|
0.95
N/A
|
0.87
-8%
|
0.62
-29%
|
0.41
-34%
|
3.03
+639%
|
5.3
+75%
|
6.98
+32%
|
11.73
+68%
|
6.1
-48%
|
7.56
+24%
|
6.68
-12%
|
16.27
+144%
|
22.51
+38%
|
18.34
-19%
|
18.31
0%
|
12.59
-31%
|
6.74
-46%
|
2.21
-67%
|
0.33
-85%
|
0.13
-61%
|
0.11
-15%
|
0.04
-64%
|
0.33
+725%
|
0.21
-36%
|
0.09
-57%
|
0.02
-78%
|
|
Switch to:
Switch to:
See Also
Discover More
